SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment

Benzinga
2024-12-26

SciSparc Ltd. (NASDAQ:SPRC) shares are rocketing on Thursday after it disclosed that AutoMax Motors Ltd., an Israeli automotive importer and distributor with which it has a merger agreement, has received its $13 million first delivery of JAC vehicles from Anhui Jianghuai Automobile Group Co., Ltd. (JAC Motors).

This marks a key milestone in AutoMax’s direct import and distribution operations initiated earlier this year under agreements with JAC Motors.

With regulatory approvals in place, AutoMax is set to begin marketing and sales activities for JAC Motors vehicles across Israel.

SciSparc has provided financial support to AutoMax, enabling the resources necessary to facilitate the JAC Motors transaction.

As part of its growth strategy, SciSparc entered into a merger agreement with AutoMax in April 2024.

If completed, this merger would expand SciSparc into the automotive sector, subject to shareholder approval and other closing conditions.

This month, SciSparc disclosed an amendment to its non-binding letter of intent (LOI) regarding the spin-off of its advanced clinical-stage pharmaceutical portfolio and equity stake in SciSparc Nutraceuticals Inc.

Price Action: SPRC shares are trading higher by 256% at $0.7874 premarket at the last check Thursday.

Read Next:

  • Pharma Company Gets FDA Green Light For Next Phase Trial For Tourette Syndrome

Image via Shutterstock.

Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market.

Get the latest stock analysis from Benzinga?

    This article SciSparc Shares Skyrocket With AutoMax's First JAC Motors Shipment originally appeared on Benzinga.com

    © 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

    免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

    热议股票

    1. 1
       
       
       
       
    2. 2
       
       
       
       
    3. 3
       
       
       
       
    4. 4
       
       
       
       
    5. 5
       
       
       
       
    6. 6
       
       
       
       
    7. 7
       
       
       
       
    8. 8
       
       
       
       
    9. 9
       
       
       
       
    10. 10